Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2
Top Cited Papers
- 1 February 2004
- journal article
- letter
- Published by Springer Science and Business Media LLC in Nature
- Vol. 427 (6974), 537-541
- https://doi.org/10.1038/nature02214
Abstract
Coumarin derivatives such as warfarin represent the therapy of choice for the long-term treatment and prevention of thromboembolic events. Coumarins target blood coagulation by inhibiting the vitamin K epoxide reductase multiprotein complex (VKOR)1. This complex recycles vitamin K 2,3-epoxide to vitamin K hydroquinone, a cofactor that is essential for the post-translational γ-carboxylation of several blood coagulation factors2,3. Despite extensive efforts, the components of the VKOR complex have not been identified4,5,6,7,8. The complex has been proposed to be involved in two heritable human diseases: combined deficiency of vitamin-K-dependent clotting factors type 2 (VKCFD2; Online Mendelian Inheritance in Man (OMIM) 607473), and resistance to coumarin-type anticoagulant drugs (warfarin resistance, WR; OMIM 122700). Here we identify, by using linkage information from three species, the gene vitamin K epoxide reductase complex subunit 1 (VKORC1), which encodes a small transmembrane protein of the endoplasmic reticulum. VKORC1 contains missense mutations in both human disorders and in a warfarin-resistant rat strain. Overexpression of wild-type VKORC1, but not VKORC1 carrying the VKCFD2 mutation, leads to a marked increase in VKOR activity, which is sensitive to warfarin inhibition.Keywords
This publication has 22 references indexed in Scilit:
- Homozygosity mapping of a second gene locus for hereditary combined deficiency of vitamin K–dependent clotting factors to the centromeric region of chromosome 16Blood, 2002
- A molecular mechanism for genetic warfarin resistance in the ratThe FASEB Journal, 2001
- Characterization and purification of the vitamin K1 2,3 epoxide reductase system from rat liverJournal of Pharmacy and Pharmacology, 2001
- Genomic assignment of the warfarin resistance locus, Rw, in the ratMammalian Genome, 1999
- Assembly of the Warfarin-sensitive Vitamin K 2,3-Epoxide Reductase Enzyme Complex in the Endoplasmic Reticulum MembranePublished by Elsevier BV ,1997
- Metabolism of vitamin K and vitamin K 2,3-epoxide via interaction with a common disulfideBiochemistry, 1984
- Warfarin inhibition of vitamin K 2,3-epoxide reductase in rat liver microsomesBiochemistry, 1983
- The Mode of Action of Vitamin KJournal of Biological Chemistry, 1974
- Vitamin K Dependent Modifications of Glutamic Acid Residues in ProthrombinProceedings of the National Academy of Sciences of the United States of America, 1974
- Heritable Resistance to Warfarin in RatsNature, 1967